BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 319-341

  Barbanti Brodano, Giuseppe ^a   Sabbioni, Silvia ^a   Martini, Fernanda ^a   Negrini, Massimo ^a   Corallini, Alfredo ^a   Tognon, Mauro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS T ANTIGEN;

BK VIRUS; CHEMISTRY; HUMAN; IMMUNOLOGY; JC VIRUS; NEOPLASM; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIMIAN VIRUS 40; VIROLOGY; VIRUS INFECTION;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BK VIRUS; HUMANS; JC VIRUS; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SIMIAN VIRUS 40;

EID: 33745631009     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_23     Document Type: Review

References (215)

1. Barbanti-Brodano G, Martini F, De Mattei M et al. BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 1998; 50:69-99.
2. Corallini A, Tognon M, Negrini M et al. Evidence for BK virus as a human tumor virus. In: Khalili K, Stoner GJ, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:431-460.
3. Tognon M, Corallini A, Martini F et al. Oncogenic transformation by BK virus and association with human tumors. Oncogene 2003; 22:5192-5200.
4. Hurault de Ligny B, Godin M, Lobbedez T et al. Virological, epidemiological and pathogenic aspects of human polyomaviruses. Presse Med 2003; 32:656-658.
5. Khalili K, Del Valle L, Otte J et al. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 2002; 22:5181-5191.
6. Garcea RL, Imperiale MJ. Simian virus 40 infection of humans. J Virol 2003; 77:5039-5045.
7. Barbanti-Brodano G, Sabbioni S, Martini F et al. Simian Virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004; 318:1-8.
8. Imperiale MJ. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 2000; 267:1-7.
9. Imperiale MJ. Oncogenic transformation by the human polyomaviruses. Oncogene 2001; 20:7917-7923
10. Imperiale MJ. The human polyomaviruses: an overview. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:53-71.
11. Moens U, Rekvig OP. Molecular biology of BK virus and cHnical and basic aspects of BK virus renal infection. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:359-408.
12. Yogo Y, Sugimoto C. The archetype concept and regulatory region rearrangement. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:127-148.
13. Loeber G, Doerries K. DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 1988; 62:1730-1735.
14. Jorgensen GE, Hammarin AL, Bratt G et al. Identification of a unique BK virus variant in the CNS of a patient with AIDS. J Med Virol 2003; 70:14-19.
15. Negrini M, Sabbioni S, Arthur RR et al. Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants. J Virol 1991; 65:5092-5095.
16. Browoi P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975; 102:331-340.
17. Gardner SD. Prevalence in England of antibody to human polyomavirus (BK). BMJ 1973; 1:77-78.
18. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784-787.
19. Portolani M, Marzocchi A, Barbanti-Brodano G et al. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol 1974; 7:543-546.
20. Padgett BL, Walker DL. Prevalence of antibodies in human sera gainst JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973; 127:467-470.
21. Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982; 26:1057-1062.
22. Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115-123.
23. Stolt A, Sasnauskas K, Koskela P et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84:1499-1504.
24. Carter JJ, Madeleine MM, Wipf GC et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003; 95:1522-1530.
25. Minor P, Pipkin P, Jarzebek Z et al. Studies of neutralising antibodies to SV40 in human sera. J Med Virol 2003; 70:490-495.
26. Monini P, De Lellis L, Barbanti-Brodano G. Association of BK and JC human polyomaviruses and SV40 with human tumors. In: Barbanti-Brodano G, Bcndinelli M, Friedman H, eds. DNA Tumor Viruses: Oncogenic Mechanisms. New York: Plenum Press, 1995:51-73.
27. Doerries K. Latent and persistent polyomavirus infection. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:197-235.
28. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611-623.
29. Blake K, Pillay D, Knowles W et al. JC virus associated meningoencephalitis in an immunocompetent girl. Arch Dis Child 1992; 67:956-957.
30. Shah KV, Nathanson N. Human exposure to SV40. Am J Epidemiol 1976; 103:1-12.
31. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 1997; 15:1877-1888.
32. Melnick JL, Stinebaugh S. Excretion of vacuolating SV40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Ep Biol Med 1962; 109:965-968.
33. Ling PD, Lednicky JA, Keitel WA et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study. J Infect Dis 2003; 187:1571-1580.
34. Li RM, Tanawattanacharoen S, Falk RA et al. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13:2320-2330.
35. Li RM, Mannon RB, Kleiner D et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002; 74:1497-1504.
36. Sweet BH, Hilleman MR. The vacuolating virus SV40. Proc Soc Exp Biol Med 1960; 105:420-427.
37. De Mattei M, Martini F, Corallini A et al. High incidence of BK virus large T antigen coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer 1995; 61:756-760.
38. Martini F, Iaccheri L, Carinci P et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996; 56:4820-4825.
39. Martini F, Lazzarin L, Iaccheri L et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002; 94:1037-1048.
40. Lecatsas G, Schoub BD, Rabson AR et al. Papovavirus in human lymphocyte cultures. Lancet 1976; 2:907-908.
41. Schneider EM, Doerries K. High frequency of polyomavirus infection in lymphoid cell preparations after allogenic bone marrow transplantation. Transplant Proc 1993; 25:1271-1273.
42. Goudsmit J, Wertheim-van Dillen P, van Strien A et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91-99.
43. Monaco MCG, Jensen PN, Hou J et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72:9918-9923.
44. Laghi L, Randolph AE, Chauhan DP et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U.S.A. 1999; 96:7484-7489.
45. Ricciardiello L, Laghi L, Ramamirtham P et al. JC virus DNA sequences are frequendy present in the human upper and lower gastrointestinal tract. Gastroenterology 2000; 119:1228-1235.
46. Ricciardiello L, Chang DK, Laghi L et al. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 2001; 75:1996-2001.
47. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P et al. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75:10290-10299.
48. Vastag B. Sewage yields clues to SV40 transmission. J Am Med Assoc 2002; 288:1337-1338.
49. Minor P, Pipkin PA, Cutler K et al. Natural infection and transmission of SV40. Virology 2003; 314:403-409.
50. Pipas JM, Levine AJ. Role of T antigen interactions with p53 in tumorigenesis. Sem Cancer Biol 2001; 11:23-30.
51. Sáenz-Robles MT, Sullivan CS, Pipas JM. Transforming functions of Simian Virus 40. Oncogene 2001; 20:7899-7907.
52. Dyson N, Buchkovich K, Whyte P et al. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989; 58:249-255.
53. Dyson N, Bernards R, Friend SH et al. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 1990; 64:1353-1356.
54. Harris KF, Christensen JB, Imperiale MJ. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol 1996; 70:2378-2386.
55. Shivakumar CV, Das GC. Interaction of human polyomavirus BK with the tumor-suppressor protein p53. Oncogene 1996; 13:323-332.
56. Sheppard HM, Siska IC, Espiritu C et al. New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen. Mol Cell Biol 1999; 19:2746-2753.
57. Baysal BE, Farr JE, Goss JR et al. Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23. Gene 1998; 217:107-116.
58. Wang SS, Esplin ED, Li JL et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998; 282: 284-287.
59. Calin GA, di Iasio MG, Caprini E et al. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000; 19:1191-1195.
60. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997; 11:3286-3305.
61. Willert K, Nusse R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998; 8:95-102.
62. Ikeda S, Kishida M, Matsuura Y et al. GSK-3b-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by b-catenin and protein phosphatase 2A complexed with Axin. Oncogene 2000; 19:537-545.
63. Nunbhakdi-Craig V, Craig L, Machleit T et al. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol 2003; 77:2807-2818.
64. Gaillard S, Fahrbach KM, Parkati R et al. Overexpression of simian virus 40 small-t antigen blocks centrosome function and mitotic progression in human fibroblasts. J Virol 2001; 75:9799-9807.
65. Zhao JJ, Gjoerup OV, Subramanian RR et al. Human mammary epithelial cell transformation through the activation of phosphatidyHnositol 3-kinase. Cancer Cell 2003; 3:483-495.
66. Beck GR Jr, Zerler BR, Moran E. Introduction to DNA tumor viruses: Adenovirus, simian virus 40, and poiyomavirus. In: McCance DJ, ed. Human Tumor Viruses. Washington, DC: ASM Press, 1998:51-86.
67. Loeken MR. Simian virus 40 small t antigen transactivates the adenovirus E2A promoter by using mechanisms distinct from those used by adenovirus E1A. J Virol 1992; 66:2551-2555.
68. Theile M, Grabowski G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch Virol 1990; 113:221-233.
69. Theile M, Strauss M, Luebbe L. SV40-induced somatic mutations: possible relevance to viral transformation. Cold Spring Harbor Symp Quant Biol 1980; 44:377-382.
70. Ray FA, Peabody DS, Cooper JL et al. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 1990; 42:13-31.
71. Stewart N, Bacchetti S. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 1991; 180:49-57.
72. Trabanelli C, Corallini A, Gruppioni R et al. Chromosomal aberrations induced by BK virus T antigen in human fibroblasts. Virology 1998; 243:492-496.
73. Tognon M, Casalone R, Martini F et al. Large T antigen coding sequences of two DNA tumor viruses, BK and SV40 and nonrandom chromosome chances in glioblastoma cell lines. Cancer Genet Cytogenet 1996; 90:17-23.
74. Lazutka JR, Neel JV, Major EO et al. High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes. Cancer Lett 1996; 109:177-183.
75. Neel JV, Major EO, Awa AA et al. Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncogenesis. Proc Natl Acad Sci U.S.A. 1996; 93:2690-2695.
76. Ricciardiello L, Baglioni M, Giovannini C et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003; 63:7256-7262.
77. Simmons DT, Melendy T, Usher D et al. Simian virus 40 large T antigen binds to topoisomerase I. Virology 1996; 222:365-374.
78. Dean FB, Bullock P, Murakami Y et al. Simian virus 40 (SV40) DNA replication: SV40 large T antigene unwinds DNA containing the SV40 origin of replication. Proc Natl Acad Sci USA 1987; 84:16-20.
79. Li D, Zhao R, Lilyestrom W et al. Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 2003; 423:512-518.
80. Shein HM, Enders JF. Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc Natl Acad Sci U.S.A. 1962; 48:1164-1172.
81. Koprowski H, Ponten JA, Jensen F et al. Transformation of cultures of human tissue infected with simian virus 40. J Cell Comp Physiol 1962; 59:281-292.
82. Jensen F, Koprowski H, Pagano JS et al. Autologous and homologous implantation of human cells transformed in vitro by simian virus 40. J Natl Cancer Inst 1964; 32:917-932.
83. Chen W, Hahn WC. SV40 early region oncoproteins and human cell transformation. Histol Histopathol 2003; 18:541-550.
84. Purchio AF, Fareed GC. Transformation of human embryonic kidney cells by human papovavirus BK. J Virol 1979; 29:763-769.
85. Grossi MP, Caputo A, Meneguzzi G et al. Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment. J Gen Virol 1982; 63:393-403.
86. Rinaldo CH, Myhre MR, Alstad H et al. Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res 2003; 93:181-187.
87. Vasavada R, Eager KB, Barbanti-Brodano G et al. Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. Proc Natl Acad Sci U.S.A. 1986; 83:5257-5261.
88. Corallini A, Pagnani M, Viadana P et al. Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene. Cancer Res 1987; 47:6671-6677.
89. Corallini A, Pagnani M, Caputo A et al. Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey-ras oncogene. J Gen Virol 1988; 69:2671-2679.
90. Pagnani M, Corallini A, Caputo A et al. Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene. Int J Cancer 1988; 42:405-413.
91. Pater A, Pater MM. Transformation of primary human embryonic kidney cells to anchorage independence by a combinant of BK virus DNA and the Harvey-ras oncogene. J Virol 1986; 58:680-683.
92. Corallini A, Gianni M, Mantovani C et al. Transformation of human cells by recombinant DNA molecules containing BK virus early region and the human activated c-H-ras or c-myc oncogenes. Cancer Journal 1991; 4:24-34.
93. Takemoto KK, Linke H, Miyamura T et al. Persistent BK papovavirus infection of transformed human fetal brain cells. I. Episomal viral DNA in cloned lines deficient in T-antigen expression. J Virol 1979; 29:1177-1185.
94. Hahn WC, Counter CM, Lundberg AS et al. Creation of human tumour cells with defined genetic elements. Nature 1999; 400:464-468.
95. London WT, Houff SA, Madden DL et al. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 1978; 201:1246-1249.
96. London WT, Houff SA, MacKeever PE et al. Viral induced astrocytomas in squirrel monkeys. In: Sever JL, Madden DL, eds. Polyomaviruses and Human Neurological Disease. New York: Alan R. Liss, 1983:227-237.
97. Chen J, Tobin GJ, Pipas JM et al. T antigen mutant activities in vivo: roles pf p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 1992; 7:1167-1175.
98. Van Dyke TA, Finlay C, Miller D et al. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J Virol 1987; 61:2029-2032.
99. Gee GV, Manley K, Atwood WJ. Derivation of a JC virus-resistant human glial cell line: implications for the identification of host cell factors that determine viral tropism. Virology 2003; 314:101-109.
100. Corallini A, Altavilla G, Carra' L et al. Oncogenicity of BK virus for immunosuppressed hamsters. Arch Virol 1982; 73:243-253.
101. Walker DL, Padgett BL, zu Rhein CM, et al. Human papovavirus (JC): Induction of brain tumors in hamsters. Science 1973; 181:674-676.
102. Del Valle L, Gordon J, Ferrante P et al. JC virus in experimental and clinical brain tumorigenesis. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:409-430.
103. Varakis JN, zu Rhein GM, Padgett BL et al. Experimental (JC virus-induced) neuroblastomas in the Syrian hamster. J Neuropathol Exp Neurol 1976; 35:314.
104. Ohashi T, zu Rhein GM, Varakis J et al. Experimental QC virus-induced) intraocular and extraorbital tumors in the Syrian hamster. J Neuropathol Exp Neurol 1978; 37:667.
105. Padgett BL, Walker DL, zu Rhein GM et al. Differential neuro-oncogenicity of strains of JC virus, a human polyomavirus, in newborn Syrian hamsters. Cancer Res 1977; 37:718-725.
106. Miller NR, McKeever PE, London WT et al. Brain tumors of owl monkeys inoculated with JC virus contain the JC virus genome. J Virol 1984; 49:848-856.
107. Major EO, Mourrain P, Cummins C. JC virus-induced owl monkey glioblastoma cells in culture: biological properties associated with the viral early gene product. Virology 1984; 136:359-367.
108. Cicala C, Pompetti F, Carbone M. SV40-induced mesotheliomas in hamsters. Am J Pathol 1993; 142:1524-1533.
109. Small JA, Khoury G, Jay G et al. Early regions of JC virus and BK virus induce distinct and tissue specific tumors in transgenic mice. Proc Natl Acad Sci U.S.A. 1986; 83:8288-8292.
110. Dalrymple SA, Beemon KL. BK virus T antigens induce kidney carcinomas and thymoproliferative disorders in transgenic mice: J Virol 1990; 64:1182-1191.
111. Brinster RL, Chen HY, Messing A et al. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984; 37:367-379.
112. Palmiter R, Chen H, Messing A et al. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature 1985; 316:457-460.
113. Feigenbaum L, Hinrichs SH, Jay G. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virol 1992; 66:1176-1182.
114. Fiori M, Di Mayorca G. Occurrence of BK virus DNA in DNA obtained from certain human tumors. Proc Natl Acad Sci USA 1976; 73:4662-4666.
115. Pater MM, Pater A, Fiori M et al. BK virus DNA sequences in human tumors and normal tissues and cell lines. In: Essex M, Todaro G, zur Hansen H, eds. Viruses in Naturally Occurring Cancers. Book A. Cold Spring Harbor Conferences on Cell Proliferation. New York: Cold Spring Harbor Laboratory Press, 1980:329-341.
116. Corallini A, Pagnani M, Viadana P et al. Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer 1987; 39:60-67.
117. Caputo A, Corallini A, Grossi MP et al. Episomal DNA of a BK virus variant in a human insulinoma. J Med Virol 1983; 12:37-49.
118. Pagnani M, Negrini M, Reschinglian P et al. Molecular and biological properties of BK virus-IR, a BK virus variant rescued from a human tumor. J Virol 1986; 59:500-505.
119. Calos MP, Miller JH. Tansposable elements. Cell 1980; 20:579-595.
120. Doerries K, Loeber G, Meixenberger J. Association of polyomavirus JC, SV40 and BK with human brain tumors. Virology 1987; 160:268-270.
121. Flaegstad T, Andresen PA, Johnsen JI et al. A possible contributory role of BK virus infection in neuroblastoma development. Cancer Res 1999; 59:1160-1163.
122. Knoll A, Stoehr R, Jilg W et al. Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas. Oncol Rep 2003; 10:487-491.
123. Monini P, Rotola A, Di Luca D et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology 1995; 214:273-279.
124. Geetha D, Tong BC, Racusen L et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73:1933-1936.
125. Zambrano A, Kalantari M, Simoneau A et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53:263-276.
126. Negrini M, Rimessi P, Mantovani C et al. Characterization of BK virus variants rescued from human tumours and tumour cell Unes. J Gen Virol 1990; 71:2731-2736.
127. Monini P, Rotola A, De Lellis L et al. Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer 1996; 66:717-722.
128. Peterman TA, Jaffe HW, Beral V. Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS 1993; 7:605-611.
129. Williams RL, Risau W, Zerwes HG et al. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989; 57:1053-1063.
130. O'Connel K, Landman G, Farmer E et al. Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcoma like tumors in nude mice. Am J Pathol 1991; 139:743-749.
131. Corallini A, Possati L, Trabanelli C et al. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta 1. Carcinogenesis 2003; 24:1435-1444.
132. Arthur RR, Grossman SA, Ronnett BM et al. Lack of association of human polyomaviruses with human brain tumors. J Neuro-Oncol 1994; 20:55-58.
133. Volter C, zur Hausen H, Alber D et al. Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses. Virology 1997; 237: 389-396.
134. MacKenzie J, Perry J, Ford AM et al. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukemia. Brit J Cancer 1999; 81:898-899.
135. Kim JY, Koralnik IJ, LeFave M et al. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro-oncology 2002; 4:165-170.
136. Rencic A, Gordon J, Otte J et al. Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci USA 1996; 93:7352-7357.
137. Caldarelli-Stefano R, Boldorini R, Monga G et al. JC virus in human glial-derived tumors. Hum Pathol 2000; 31:394-395.
138. Del Valle L, Gordon J, Enam S et al. Expression of human neutropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst 2002; 94:267-273.
139. Boldorini R, Caldarelli-Stefano R, Monga G et al. PCR detection of JC virus DNA in the brain tissue of a 9-year-old child with pleomorphic xanthoastrocytoma. J Neurovirol 1998; 4:242-245.
140. Krynska B, Del Valle L, Croul S et al. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 1999; 96:11519-11524.
141. Krynska B, Otte J, Franks R et al. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 1999; 18:39-46.
142. Del Valle L, Gordon J, Assimakopoulou M et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 2001; 61:4287-4293.
143. Del Valle L, Delbue S, Gordon J et al. Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme. Neurology 2002; 58:895-900.
144. Del Valle L, Enam S, Lara C et al. Detection of JC polyomavirus DNA sequences and cellular localization of T-antigen and agnoprotein in oligodendrogliomas. Clin Cancer Res 2002; 8:3332-3340.
145. Boldorini R, Pagani E, Car PG et al. Molecular characterisation of JC virus strains detected in human brain tumours. Pathology 2003; 35:248-253.
146. Safak M, Barrucco R, Darbinyan A et al. Interaction of JC virus agnoprotein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 2001; 75:1476-1486.
147. Endo S, Okada Y, Orba Y et al. JC virus agnoprotein colocalizes with tubulin. J Neurovirol 2003; 9 Suppl 1:10-14.
148. Enam S, Del Valle L, Lara C et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002; 62:7093-7101.
149. Can DD, Reiss K, Gorrill T et al. Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene 2001; 20:4864-4870.
150. Galdenzi G, Lupo A, Anglani F et al. Is the simian virus SV40 associated with idiopathic focal segmental glomerulosclerosis in humans? J Nephrol 2003; 16:350-356.
151. Arrington AS, Butel JS. SV40 and human tumors. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:461-489.
152. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nature Rev Cancer 2002; 2:957-964.
153. Vilchez RA, Butel JS. SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene 2003; 22:5164-5172.
154. Mendoza SM, Konishi T, Miller CW. Integration of SV40 in human osteosarcoma DNA. Oncogene 1998; 17:2457-2462.
155. Pacini F, Vivaldi A, Santoro M et al. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 1998; 16:665-669.
156. Lednicky JA, Garcea RL, Bergsagel DJ et al. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 1995; 212:710-717.
157. Capello D, Rossi D, Gaudino G et al. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003; 361:88-89.
158. De Sanjose S, Shah KV, Domingo-Domenench E et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003; 104:522-524.
159. Engels EA, Sarkar C, Daniel RW et al. Absence of simian virus 40 in human brain tumors from Northern India. Int J Cancer 2002; 101:348-352.
160. Gordon GJ, Chen CJ, Jaklitsch MT et al. Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. Oncol Rep 2002; 9:631-634.
161. MacKenzie J, Wilson KS, Perry J et al. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003; 95:1001-1003.
162. Mayall F, Barratt K, Shanks J. The detection of simian virus 40 in mesotheliomas from New Zeland and England using real time FRET probe PCR protocols. J Clin Pathol 2003; 56:728-730.
163. Shah KV. Does SV40 infection contribute to the development of human cancers? Rev Med Virol 2000; 10:31-43.
164. Strickler HD and The International SV40 Working Group. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol Biomark Prev 2001; 10:523-532.
165. Carbone M, Bocchetta M, Cristaudo A et al. SV40 and human brain tumors. Int J Cancer 2003; 106:140-142.
166. Engels EA, Gravitt PE, Daniel RW et al. Absence of simian virus 40 in human brain tumors from Northern India; response to letter from Carbone et al. Int J Cancer 2003; 106:143-145.
167. RoUison DEM, Helzlsouer KJ, Alberg AJ et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomark Prev 2003; 12:460-463.
168. Engels EA, Rodman LH, Frisch M et al. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer 2003; 106:283-287.
169. zur Hausen H. SV40 in humans cancers: an endless tale? Int J Cancer 2003; 107:687.
170. Testa JR, Carbone M, Hirvonen A et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res 1998; 58:4505-4509.
171. Vilchez RA, Butel JS. Simian virus 40 and its association with human lymphomas. Curr Oncol Rep 2003; 5:372-379.
172. Vilchez RA, Kozinetz CA, Arrington AS et al. Simian virus 40 in human cancers. Am J Med 2003; 114:675-684.
173. Brugge JS, Butel, JS. Role of simian virus 40 gene A function in maintenance of transformation. J Virol 1975; 15:619-635.
174. Martin RG, Chou JY.Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J Virol 1975; 15:599-612.
175. Osborn M, Weber K. Simian virus 40 gene A function and maintenance of transformation. J Virol 1975; 15:636-644.
176. Tegtmeyer P. Function of simian virus 40 gene A in transforming infection. J Virol 1975; 15:613-618.
177. Coleman WB, Tsongalis GJ. The role of genomic instability in the development of human cancer. In: Coleman WB, Tsongalis GJ, eds. The Molecular Basis of Human Cancer. Totowa: Humana Press, 2002:115-142.
178. Reinartz JJ. Cancer genes. In: Coleman WB, Tsongalis GJ, eds. The Molecular Basis of Human Cancer. Totowa, NJ: Humana Press, 2002:45-64.
179. Shimamoto T, Ohyashiki K. Chromosomes and chromosomal instability in human cancer. In: Coleman WB, Tsongalis GJ, eds. The Molecular Basis of Human Cancer. Totowa: Humana Press, 2002:143-158.
180. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396:643-649.
181. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit and run' mechanism. Nature 1983; 302:21-24.
182. Schlehofer JR, zur Hausen H. Induction of mutations within the host cell genome by partially inactivated herpes simplex virus type 1. Virology 1982; 122:471-475.
183. Porcu P, Ferber A, Pietrzkowski Z et al. The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor 1 with its receptor. Mol Cell Biol 1992; 12:5069-5077.
184. Cacciotti P, Libener R, Betta P et al. SV40 replication in human mesothelial cells induces HGF/ Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci USA 2001; 98:12032-12037.
185. Cacciotti P, Strizzi L, Vianale G et al. The presence of simian virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am J Respir Cell Mol Biol 2002; 26:189-193.
186. Catalano A, Romano M, Martinotti S et al. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene 2002; 21:2896-2900.
187. Carbone M, Pass HI, Miele L et al. New developments about the association of SV40 with human mesothelioma. Oncogene 2003; 22:5173-5180.
188. Carbone M, Rizzo P, Grimley PM et al. Simian virus-40 large T-antigen binds p53 in human mesotheliomas. Nature Med 1997; 3:908-912.
189. De Luca A, Baldi A, Esposito V et al. The retinoblastoma gene family pRb/p105, p107, pRb2/ p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Med 1997; 3:913-916.
190. Bocchetta M, Miele L, Pass HI et al. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003; 22:81-89.
191. Waheed I, Guo ZS, Chen GA et al. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res 1999; 59:6068-6073.
192. Bright RK, Kimchl ET, Shearer MH et al. SV40 Tag-specific cytotoxic T lymphocytes generated from the pheripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother 2002; 50:682-690.
193. Procopio A, Strizzi L, Vianale G et al. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chrom Cancer 2000; 29:173-179.
194. Bocchetta M, Di Resta I, Powers A et al. Human mesothelial cells are unusually susceptible to SV40-mediated transformation and asbestos co-carcinogenicity. Proc Natl Acad Sci U S A 2000; 97:10214-10219.
195. Carbone M, Burck C, Rdzanek M et al. Different susceptibiUty of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Res 2003; 63:6125-6129.
196. Dubes GR. Asbestos mediates viral DNA transformation of mouse cells to produce multilayered foci. Proc Am Assoc Cancer Res 1993; 34:185.
197. Cristaudo A, Foddis R, Bigdeli L et al. SV40: a possible co-carcinogen of asbestos in the pathogenesis of mesothelioma? Med Lav 2002; 93:499-506.
198. Dopp E, Poser I, Papp T. Interphase FISH analysis of cell cycle genes in asbestos-treated human mesothelial cells (HMC), SV40-transformed HMC (MET-5A) and mesothelioma cells (COLO). Cell Mol Biol 2002; 48:271-277.
199. Foddis R, De Rienzo A, Broccoli D et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21:1434-1442.
200. Stratton K, Almario DA, McCormick MC. SV40 contamination of polio vaccine and cancer. Immunization Safety Review Committee, Board of Health Promotion and Disease Prevention, Institute of Medicine of the National Academies. Washington DC: National Academies Press, 2002 (www.nap.edu)
201. Vilchez RA, Kozinetz A, Butel JS. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 2003; 4:188-191.
202. Imperiale MJ, Pass HI, Sanda MG. Prospects for an SV40 vaccine. Semin Cancer Biol 2001; 11:81-85.
203. Xie YC, Hwang C, Overwijk W et al. Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst 1999; 91:169-175.
204. Kennedy RC, Shearer MH, Watts AM et al. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Cancer Res 2003; 63:1040-1045.
205. Cho KB, Chong KY. Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 1993; 193:1042-1046.
206. Lee YY, Wilcznyski SP, Chumakov A et al. Carcinoma of the vulva: HPV and p53 mutations. Oncogene 1994; 9:1655-1659.
207. Goedert JJ, ed. Infectious causes of cancer. Totowa: Humana Press, 2000.
208. Newton R, Beral V, Weiss RA, eds. Infections and human cancer. Cancer Surveys vol 33. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999.
209. McNally RJQ, Cairns DP, Eden OB et al. An infectious aetiology for childhood brain tumours? Evidence from space - Time clustering and seasonality analyses. British J Cancer 2002; 86:1070-1077.
210. Larsen LS. Brain tumors incidence rising; researchers ask why. J Natl Cancer Inst 1993; 85:1024-1025.
211. Mortimer EA Jr, Lepow ML, Gold E et al. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981; 305:1517-1518.
212. Geissler E. SV40 and human tumors. Prog Med Virol 1990; 37:211-222.
213. CarroU-Pankhurst C, Engels EA, Strickler HD et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Brit J Cancer 2001; 85:1295-1297.
214. zur Hausen H. Viruses in human cancers. Science 1991; 254:1167-1173.
215. zur Hausen H. Viral oncogenesis. In: Parsonnet J, ed. Microbes and Malignancy. New York: Oxford Press, 1999:107-130.